|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5194 USD | -0.02% |
|
+33.18% | +15.42% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.91M 1.76M 1.65M 3.09M 205M 3.15M 21.15M 8.19M 101M 8.17M 7.99M 352M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.84M 10.91M 10.21M 19.14M 1.27B 19.55M 131M 50.77M 628M 50.63M 49.52M 2.18B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.86% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -0.02% | ||
| 1 week | +33.18% | ||
| Current month | +40.38% | ||
| 1 month | -0.10% | ||
| 3 months | +79.10% | ||
| 6 months | +44.32% | ||
| Current year | +15.42% |
| 1 week | 0.5 |  | 0.52 |
| 1 month | 0.37 | | 0.52 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.02% | +33.18% | +47.56% | -51.91% | 3.77M | |
| +7.13% | +9.97% | +51.94% | +166.83% | 1,077B | |
| +3.99% | +11.50% | +67.53% | +55.63% | 613B | |
| +4.20% | +17.03% | +35.63% | +87.74% | 448B | |
| +0.99% | +4.85% | +27.93% | +22.82% | 332B | |
| +1.82% | +8.19% | +41.15% | +26.80% | 293B | |
| +0.22% | +6.75% | +31.51% | +42.02% | 286B | |
| +0.73% | +8.53% | -26.22% | -40.85% | 215B | |
| +1.56% | +6.14% | +28.38% | +59.45% | 193B | |
| +3.26% | +3.33% | +18.83% | +67.03% | 159B | |
| Average | +2.39% | +7.20% | +32.42% | +43.56% | 361.61B | |
| Weighted average by Cap. | +3.85% | +8.93% | +40.51% | +81.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.27M 18.68M 17.48M 32.75M 2.18B 33.45M 224M 86.89M 1.07B 86.64M 84.74M 3.73B | 24.22M 21.27M 19.6M 18.34M 34.37M 2.28B 35.11M 236M 91.19M 1.13B 90.93M 88.94M 3.92B |
| Net income | -5.27M -4.63M -4.26M -3.99M -7.48M -497M -7.64M -51.22M -19.84M -245M -19.78M -19.34M -852M | -3.2M -2.81M -2.59M -2.43M -4.55M -302M -4.64M -31.15M -12.06M -149M -12.03M -11.76M -518M |
| Net Debt | 10.2M 8.96M 8.25M 7.72M 14.47M 962M 14.78M 99.17M 38.4M 475M 38.29M 37.45M 1.65B | 11.31M 9.93M 9.15M 8.57M 16.05M 1.07B 16.39M 110M 42.58M 526M 42.46M 41.53M 1.83B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/26 | $0.5194 | -0.02% | 1,500 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
